Concord Medical (NYSE: CCM) highlights Hong Kong unit’s 2025 interim results

Rhea-AI Filing Summary

Concord Medical Services Holdings Limited filed a report noting that its subsidiary, Concord Healthcare Group Co., Ltd., announced interim results on the Main Board of The Stock Exchange of Hong Kong Limited for the six months ended June 30, 2025. Concord Healthcare’s H shares trade on the HKSE under stock code 2453.HK, while the parent company remains listed on the NYSE under the symbol CCM.

The filing directs investors to the Hong Kong exchange website for detailed information on Concord Healthcare’s transactions and interim financial results.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number: 001-34563

CONCORD MEDICAL SERVICES HOLDINGS LIMITED

Room A1-A5 26/F, East Zone, Hanwei Plaza

No. 7 Guanghua Road, Chaoyang District,

Beijing 100020

People’s Republic of China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F          x                    Form 40-F          ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

Concord Healthcare Announces Interim Results on The Stock Exchange of Hong Kong Limited

Concord Healthcare Group Co., Ltd. (“Concord Healthcare”), a subsidiary of Concord Medical Services Holdings Limited (the “Company”) (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the “HKSE”) under the stock code 2453.HK, announced its interim results for the six months ended June 30, 2025 on August 28, 2025.

The Company previously announced the listing of Concord Healthcare’s H shares on the HKSE on January 9, 2024. The information related to Concord Healthcare’s Transactions on the HKSE is accessible through the HKSE’s website at www.hkexnews.hk.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CONCORD MEDICAL SERVICES HOLDINGS LIMITED
	By:	/s/ Jianyu Yang
	Name:	Jianyu Yang
	Title:	Chairman and Chief Executive Officer

Date: August 28, 2025

FAQ

What did Concord Medical Services (CCM) disclose in this Form 6-K?

The company reported that its subsidiary Concord Healthcare Group Co., Ltd. announced interim results for the six months ended June 30, 2025 on the Hong Kong Stock Exchange.

Which subsidiary of CCM announced interim results and where is it listed?

The subsidiary is Concord Healthcare Group Co., Ltd., listed on the Main Board of The Stock Exchange of Hong Kong Limited under stock code 2453.HK.

What period do Concord Healthcare’s interim results cover?

The interim results cover the six months ended June 30, 2025.

Where can investors find detailed information on Concord Healthcare’s HKSE transactions?

Details related to Concord Healthcare’s transactions and interim results are available on the Hong Kong exchange website at www.hkexnews.hk.

When did Concord Healthcare list its H shares on the HKSE?

The company previously announced the listing of Concord Healthcare’s H shares on the HKSE on January 9, 2024.

Who signed this report for Concord Medical Services Holdings Limited?

The report was signed by Jianyu Yang, who serves as Chairman and Chief Executive Officer of Concord Medical Services Holdings Limited.